The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ABCELLERA BIOLOGICS INC | COM | 00288U106 | 8,048 | 200,000 | SH | SOLE | 0 | 200,000 | 0 | ||
ADAPTIVE BIOTECHNOLOGIES COR | COM | 00650F109 | 42,167 | 713,125 | SH | SOLE | 0 | 713,125 | 0 | ||
ADVERUM BIOTECHNOLOGIES INC | COM | 00773U108 | 39,566 | 3,650,000 | SH | SOLE | 0 | 3,650,000 | 0 | ||
AGIOS PHARMACEUTICALS INC | COM | 00847X104 | 102,909 | 2,375,000 | SH | SOLE | 0 | 2,375,000 | 0 | ||
ALECTOR INC | COM | 014442107 | 24,965 | 1,650,000 | SH | SOLE | 0 | 1,650,000 | 0 | ||
ALLOGENE THERAPEUTICS INC | COM | 019770106 | 23,852 | 945,000 | SH | SOLE | 0 | 945,000 | 0 | ||
ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 101,377 | 780,000 | SH | SOLE | 0 | 780,000 | 0 | ||
AMYRIS INC | COM | 03236M200 | 12,350 | 2,000,000 | SH | Call | SOLE | 0 | 2,000,000 | 0 | |
BLACK DIAMOND THERAPEUTICS I | COM | 09203E105 | 9,275 | 289,395 | SH | SOLE | 0 | 289,395 | 0 | ||
BEAM THERAPEUTICS INC | COM | 07373V105 | 37,554 | 460,000 | SH | SOLE | 0 | 460,000 | 0 | ||
BEIGENE LTD | SPONSORED ADR | 07725L102 | 38,759 | 150,000 | SH | SOLE | 0 | 150,000 | 0 | ||
BIOLIFE SOLUTIONS INC | COM NEW | 09062W204 | 296,786 | 7,440,107 | SH | SOLE | 0 | 7,440,107 | 0 | ||
BERKELEY LTS INC | COM | 084310101 | 17,882 | 200,000 | SH | SOLE | 0 | 200,000 | 0 | ||
BLUEBIRD BIO INC | COM | 09609G100 | 39,592 | 915,000 | SH | SOLE | 0 | 915,000 | 0 | ||
BRISTOL-MYERS SQUIBB CO | RIGHT 99/99/9999 | 110122157 | 4,313 | 6,250,000 | SH | SOLE | 0 | 6,250,000 | 0 | ||
BURNING ROCK BIOTECH LTD | SPONSORED ADS | 12233L107 | 44,402 | 1,922,150 | SH | SOLE | 0 | 1,922,150 | 0 | ||
BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 173,833 | 1,550,000 | SH | SOLE | 0 | 1,550,000 | 0 | ||
C4 THERAPEUTICS INC | COM STK | 12529R107 | 1,325 | 40,000 | SH | SOLE | 0 | 40,000 | 0 | ||
CODIAK BIOSCIENCES INC | COM | 192010106 | 2,477 | 76,688 | SH | SOLE | 0 | 76,688 | 0 | ||
CAREDX INC | COM | 14167L103 | 86,457 | 1,193,335 | SH | SOLE | 0 | 1,193,335 | 0 | ||
CODEXIS INC | COM | 192005106 | 94,524 | 4,330,000 | SH | SOLE | 0 | 4,330,000 | 0 | ||
CONSTELLATION PHARMCETICLS I | COM | 210373106 | 51,408 | 1,785,000 | SH | SOLE | 0 | 1,785,000 | 0 | ||
CRISPR THERAPEUTICS AG | NAMEN AKT | H17182108 | 40,793 | 266,430 | SH | SOLE | 0 | 266,430 | 0 | ||
DERMTECH INC | COM | 24984K105 | 44,443 | 1,370,000 | SH | SOLE | 0 | 1,370,000 | 0 | ||
DENALI THERAPEUTICS INC | COM | 24823R105 | 109,726 | 1,310,000 | SH | SOLE | 0 | 1,310,000 | 0 | ||
DYNE THERAPEUTICS INC | COM | 26818M108 | 7,770 | 370,000 | SH | SOLE | 0 | 370,000 | 0 | ||
EXACT SCIENCES CORP | COM | 30063P105 | 196,767 | 1,485,149 | SH | SOLE | 0 | 1,485,149 | 0 | ||
FATE THERAPEUTICS INC | COM | 31189P102 | 277,337 | 3,050,000 | SH | SOLE | 0 | 3,050,000 | 0 | ||
4D MOLECULAR THERAPEUTICS IN | COM | 35104E100 | 32,354 | 780,555 | SH | SOLE | 0 | 780,555 | 0 | ||
FOGHORN THERAPEUTICS INC | COM | 344174107 | 4,383 | 216,216 | SH | SOLE | 0 | 216,216 | 0 | ||
FULCRUM THERAPEUTICS INC | COM | 359616109 | 14,534 | 1,241,176 | SH | SOLE | 0 | 1,241,176 | 0 | ||
GENERATION BIO CO | COM | 37148K100 | 45,678 | 1,611,214 | SH | SOLE | 0 | 1,611,214 | 0 | ||
GLOBAL BLOOD THERAPEUTICS IN | COM | 37890U108 | 35,081 | 810,000 | SH | SOLE | 0 | 810,000 | 0 | ||
GLOBAL BLOOD THERAPEUTICS IN | COM | 37890U108 | 2,166 | 50,000 | SH | Call | SOLE | 0 | 50,000 | 0 | |
IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 25,520 | 550,000 | SH | SOLE | 0 | 550,000 | 0 | ||
KRONOS BIO INC | COM | 50107A104 | 17,427 | 583,436 | SH | SOLE | 0 | 583,436 | 0 | ||
908 DEVICES INC | COM | 65443P102 | 23,150 | 406,502 | SH | SOLE | 0 | 406,502 | 0 | ||
MAGENTA THERAPEUTICS INC | COM | 55910K108 | 26,233 | 3,346,034 | SH | SOLE | 0 | 3,346,034 | 0 | ||
INVITAE CORP | COM | 46185L103 | 514,181 | 12,298,038 | SH | SOLE | 0 | 12,298,038 | 0 | ||
ORIC PHARMACEUTICALS INC | COM | 68622P109 | 20,361 | 601,515 | SH | SOLE | 0 | 601,515 | 0 | ||
PACIFIC BIOSCIENCES CALIF IN | COM | 69404D108 | 129,700 | 5,000,000 | SH | SOLE | 0 | 5,000,000 | 0 | ||
RELAY THERAPEUTICS INC | COM | 75943R102 | 158,298 | 3,808,894 | SH | SOLE | 0 | 3,808,894 | 0 | ||
REVOLUTION MEDICINES INC | COM | 76155X100 | 64,711 | 1,634,535 | SH | SOLE | 0 | 1,634,535 | 0 | ||
SEER INC | COM CL A | 81578P106 | 8,421 | 150,000 | SH | SOLE | 0 | 150,000 | 0 | ||
SANGAMO THERAPEUTICS INC | COM | 800677106 | 16,853 | 1,080,000 | SH | SOLE | 0 | 1,080,000 | 0 | ||
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 10,008 | 450,000 | SH | SOLE | 0 | 450,000 | 0 | ||
SAREPTA THERAPEUTICS INC | COM | 803607100 | 90,360 | 530,000 | SH | SOLE | 0 | 530,000 | 0 | ||
STOKE THERAPEUTICS INC | COM | 86150R107 | 7,432 | 120,000 | SH | SOLE | 0 | 120,000 | 0 | ||
TURNING POINT THERAPEUTICS I | COM | 90041T108 | 9,139 | 75,000 | SH | SOLE | 0 | 75,000 | 0 | ||
TAYSHA GENE THERAPIES INC | COM SHS | 877619106 | 21,774 | 820,440 | SH | SOLE | 0 | 820,440 | 0 | ||
TWIST BIOSCIENCE CORP | COM | 90184D100 | 141,290 | 1,000,000 | SH | SOLE | 0 | 1,000,000 | 0 | ||
ZAI LAB LTD | ADR | 98887Q104 | 25,715 | 190,000 | SH | SOLE | 0 | 190,000 | 0 |